Click Here To View
Latest Insulin Articles
Popular Insulin Articles
Highly Recommended Insulin Articles
Send a link to this page to your friends and colleagues.
Novocell, Inc., a San Diego, California-based stem cell engineering company, announced on October 19, 2006, the development of a process that “efficiently converts human embryonic stem cells into insulin-producing pancreatic endocrine cells.”
“Such an approach could provide a means to produce sufficient quantities of insulin-producing cells for transplantation into patients with type 1 diabetes,” writes Novocell in a press release, “a treatment that offers a potential therapy for this disease.”
* * *
Source: Novocell, Inc.
0 comments - Feb 1, 2007